Activities per year
Activities
- 25 results
Search results
-
Hyperuricemia and Deposition: Evidence-Based Recommendations and Clinical Findings
Mackenzie, I. (Speaker)
1 Jun 2024Activity: Talk or presentation types › Invited talk
-
BedMed, BedMed-Frail and TIME. Evening dosing of antihypertensive medications.
Mackenzie, I. (Speaker)
5 Nov 2024Activity: Talk or presentation types › Invited talk
-
Decentralised clinical trials in the UK and beyond.
Mackenzie, I. (Speaker)
17 May 2024Activity: Talk or presentation types › Invited talk
-
Maintaining data access approvals.
Mackenzie, I. (Speaker)
11 Sept 2024Activity: Talk or presentation types › Invited talk
-
Decentralised clinical trials
Mackenzie, I. (Speaker)
17 Apr 2024Activity: Talk or presentation types › Invited talk
-
Hypertension: New drugs, new interventions
Mackenzie, I. (Speaker)
21 Nov 2024Activity: Talk or presentation types › Invited talk
-
Discussant for Hotline Session 2: BedMed, BedMed Frail, meta-analysis of timing of antihypertensive therapies studies. Chair of Meet the Trialist session (BedMed).
Mackenzie, I. (Speaker)
31 Aug 2024Activity: Talk or presentation types › Invited talk
-
Clinical trials: improving the experience
Mackenzie, I. (Speaker)
14 Mar 2024Activity: Talk or presentation types › Invited talk
-
Lipids symposium. Evolution of lipid lowering therapies. Lowering LDL: approaches and a perspective from Tayside
Mackenzie, I. (Speaker)
21 Nov 2024Activity: Talk or presentation types › Invited talk
-
Decentralised trials talk and panel member
Mackenzie, I. (Speaker)
30 Sept 2024Activity: Talk or presentation types › Invited talk
-
WP1 BEST update AND Chair of panel discussion: Future lookout for the DCT field, empowering sites and patients’ preferences. Are we moving too much burden to sites and patients?
Mackenzie, I. (Speaker)
5 Dec 2024 → 6 Dec 2024Activity: Talk or presentation types › Invited talk
-
Decentralised clinical trials: a UK trialist’s experience.
Mackenzie, I. (Speaker)
7 Oct 2024Activity: Talk or presentation types › Invited talk
-
WP1 SHAPE update and smart labels
Mackenzie, I. (Speaker)
14 May 2024 → 15 May 2024Activity: Talk or presentation types › Invited talk
-
Decentralised clinical trials
Mackenzie, I. (Speaker)
17 Mar 2023Activity: Talk or presentation types › Invited talk
-
Febuxostat: another repurposing drug? From hyperuricaemia to cardiovascular disease.
Mackenzie, I. (Speaker)
6 Oct 2023Activity: Talk or presentation types › Invited talk
-
Decentralised trials - background and wider landscape
Mackenzie, I. (Speaker)
24 Nov 2023Activity: Talk or presentation types › Invited talk
-
Allopurinol and cardiovascular outcomes
Mackenzie, I. (Speaker)
3 Mar 2023Activity: Talk or presentation types › Invited talk
-
Allopurinol in CVD (ALL-HEART)
Mackenzie, I. (Speaker)
20 Jul 2023Activity: Talk or presentation types › Invited talk
-
Decentralised clinical trials - ALL-HEART and TIME
Mackenzie, I. (Speaker)
27 Apr 2023Activity: Talk or presentation types › Invited talk
-
TIME to face the reality about evening dosing of antihypertensive drugs in hypertension.
Mackenzie, I. (Speaker)
25 Jun 2023Activity: Talk or presentation types › Invited talk
-
ALL-HEART study - hotline presentation
Mackenzie, I. (Speaker)
27 Aug 2022Activity: Talk or presentation types › Invited talk
-
Decentralised clinical trials
Mackenzie, I. (Speaker)
6 Oct 2022Activity: Talk or presentation types › Invited talk
-
Adherence and treatment resistance
Mackenzie, I. (Speaker)
Apr 2021Activity: Talk or presentation types › Invited talk
-
Endocrine hypertension
Mackenzie, I. (Speaker)
28 Oct 2021Activity: Talk or presentation types › Invited talk
-
Decentralised trials, remote monitoring and digital health. Learnings from the pandemic.
Mackenzie, I. (Speaker)
9 Nov 2021Activity: Talk or presentation types › Invited talk